Related Experiment Videos
Congenital hypofibrinogenemia in pregnancy
1Department of Obstetrics and Gynecology, Maricopa Medical Center, Phoenix, Arizona.
Obstetrical & Gynecological Survey
|March 1, 1989
Summary
Congenital hypofibrinogenemia, a rare blood disorder, can increase risks during pregnancy, including spontaneous abortion and postpartum hemorrhage. Early recognition and management are crucial for maternal and fetal well-being.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Reproductive Medicine
Background:
- Congenital hypofibrinogenemia is a rare inherited bleeding disorder characterized by extremely low levels of fibrinogen.
- Pregnancy presents unique hemostatic challenges, potentially exacerbating bleeding risks in women with hypofibrinogenemia.
Observation:
- This report details a new case of congenital hypofibrinogenemia diagnosed during pregnancy.
- A comprehensive review of existing literature was conducted, focusing on obstetric implications.
Findings:
- Congenital hypofibrinogenemia is associated with an increased risk of spontaneous abortion.
- Evidence suggests a link between this condition and placental abruption and postpartum hemorrhage.
- Management strategies for pregnant individuals with hypofibrinogenemia are presented.
Implications:
- This case highlights the importance of considering congenital hypofibrinogenemia in pregnant patients with bleeding complications.
- Optimal management may involve multidisciplinary collaboration between obstetricians and hematologists.
- Further research into the specific obstetric risks and management protocols for congenital hypofibrinogenemia is warranted.